Norbert Prenzel is an accomplished professional with a wealth of experience in business development, licensing, and strategy consulting across various industries. He holds a PhD in Molecular & Cell Biology from the Max Planck Institute for Biochemistry Martinsried and a Diploma in Chemistry from the Julius Maximilians University of Würzburg. He also pursued further education, including an EMBA from Northwestern University's Kellogg School of Management and an MBA in Economics from Kellogg-WHU Executive MBA.

Prenzel's career started as a PhD student in Axel Ullrich's lab at Max Planck Institute of Biochemistry. From there, he co-founded and managed Business Development at U3 Pharma GmbH, built and led business development at Micromet GmbH, and served as the Licensing Director at Amgen. He currently holds the position of Head of Business Development and Licensing at SOTIO.

Throughout his career, Prenzel has become a respected authority in business development and licensing in the life sciences industry. He is driven by a strong passion for turning scientific breakthroughs into transformative therapies that can impact society positively. With his exceptional education and exhaustive industry experience, he brings both scientific and business acumen to his work.